Synopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday…
January 2022
-
-
AgrochemicalsGlobal Market
Nordic Nanovector Provides update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma
by adminby adminSummary : –Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu…
-
AgrochemicalsGlobal Market
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
by adminby adminSummary : Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, with a grant date of January 6, 2022, as an inducement material to…
-
AgrochemicalsIndia
Maharashtra health minister Rajesh Tope inaugurates Bharat Serums and Vaccines’ R&D centre at Airoli
by adminby adminSummary : -Maharashtra health minister Rajesh Tope has inaugurated Bharat Serums and Vaccines (BSV)’s research and development centre at Airoli. -BSV, a…
-
AgrochemicalsIndia
Haryana sets up most number of Ayurvedic Manufacturing Units in 2020-21
by adminby adminSynopsis: The State of Haryana has seen the highest number of new companies manufacturing ayurvedic medicines registered during the fiscal year 2020-21,…
-
AstraZenecaGlobal Market
AstraZeneca, Neurimmune Sign Exclusive Collaboration and License Agreement for NI006
by adminby adminSynopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…
-
AgrochemicalsCovid DrugsIndia
Indomethacin highly efficacious in treating Covid infection: Study
by adminby adminIndomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director…
-
Global MarketRegulatoryU.S FDA
US FDA clears Jubilant Therapeutics’ IND for novel dual LSD1 & HDAC6 inhibitor, JBI-802 for treatment of solid tumours
by adminby adminSynopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND)…
-
Synopsis : This strain of the SARS-CoV-2 carries the N501Y mutation While the world is pulling in resources to fight back against…
-
AgrochemicalsGlobal Market
Bragar Eagel & Squire, P.C. Is Investigating LifeStance Health, Lockheed Martin, CareDx, and Seer and Encourages Investors to Contact the Firm
by adminby adminBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ:…
